VolitionRx Announces Proposed Underwritten Public Offering of Common Stock
AUSTIN, Texas, May 19, 2020 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company that applies its Nucleosomics™ platform through its subsidiaries to develop simple, easy to use, cost-effective blood tests to help diagnose a range of cancers a...
VolitionRx Announces Closing of $8.4 Million Public Offering of Common Stock
ISNES, Belgium, March 13, 2018 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national life sciences company focused on developing simple, easy to use, cost effective blood tests designed to help diagnose a range of cancers, announced today the closing of its prev...
VolitionRx Announces Pricing of $8.4 Million Public Offering of Common Stock
ISNES, Belgium, March 9, 2018 /PRNewswire/ -- VolitionRx Limited
VolitionRx Announces Proposed Underwritten Public Offering of Common Stock
NAMUR, Belgium, March 8, 2018 /PRNewswire/ -- VolitionRx Limited
